Featuring news, events and industry trends
Clarapath, Medical Robotics Company, Raises $32M in Additional Funding
Hawthorne-based Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissues, announced a follow-on financing, extending its Series B round with an additional $16 million in funding, following the previous close of $16 million in Series B funding. The round included The 4100 Group, East Post Road Ventures (Investment Arm of White Plains Hospital), Epiphron Capital, Northwell Ventures, P5 Health Ventures, and participation from other strategic organizations. This brings the total raised by Clarapath to more than $39 million. Clarapath is automating processes around the way tissue is processed onto glass slides via “sectioning,” or cutting a cross-section of the tissue specimen.

Regeneron Listed on Dow Jones Sustainability World Index for Third Consecutive Year

DJSI World is a global index comprised of the top 10 percent of most sustainable companies in each industry based on performance across environmental, social and governance (ESG) criteria. It is published by S&P Dow Jones Indices, one of the world's leading index providers, together with RobecoSAM, which specializes in ESG data and benchmarking. Regeneron is one of only six companies in the biotechnology sector to be included on this year's DJSI World list, and was among 2,500 global companies eligible for inclusion.

Nutrition21 Acquired as Part of New Investment Platform

Harrison based top-shelf branded ingredient supplier Nutrition21 was acquired by a private equity firm intent on building an attractive ingredients holding company.

Everwell Health Holdings is a new consumer health and wellness functional ingredients platform. Its mission is to actively pursue partnerships and business development opportunities with additional functional ingredient companies, and will focus on amplifying investments in clinical studies, new product development, marketing and sales.

Nutrition21, led by president Joe Weiss, is a developer and marketer of high-value, clinically substantiated ingredients for use in dietary supplements, foods and beverages. Its ingredient portfolio includes the brands Nitrosigine, Velositol, Chromax, Lustriva, and nooLVL.
Crossing the Valley of Death: Lab to IPO and Lab to Acquisition, November 30 at 1 PM

On November 30th hear from Josep Bassaganya-Riera, Chairman and CEO Landos BioPharma, and Matthew Meyer, former Chief Business officer CAREDx and now Chief Buisness Advisor Wilson Sonsini, as they share their journey crossing the chasm to lead ventures from academia to the public market.

Immediately following the Q&A portion of the panel, you'll have an opportunity to meet and talk with the speakers at virtual tables.

Date: November 30, 2021
Time: 1:00 PM – 2:30 PM
Navigating Technology Transfers from Research Institutions, December 9 at 12 PM

Research institutions like universities and federal research labs, are gold mines of key opinion leaders and innovative technologies that can be mined by entrepreneurs. Technology transfer professionals are working to build partnerships with entrepreneurs to bring technologies to market. These professionals can help companies find expert advisors, service providers, and funding to grow your company and demonstrate value in the clinic. Through a panel discussion and live Q&A with seasoned experts, you'll learn how to partner with research institutions.

Please join this Society of Physician Entrepreneurs (SoPE) and GW Technology Commercialization Office webinar on December 9, 2021 and learn how medical startup companies can transfer technologies from research institutions.

Date: December 9, 2021
Time: 12:00 PM

Have good news to share from
Westchester’s biosciences ecosystem?

Please let us know.

If you would like to continue receiving this weekly newsletter,
please sign up below. If you would like to contact us directly, click the Contact Us link.